MoneyWorks4Me

The total revenue for the quarter ended September 2021 remained nearly unchanged at Rs. 5378.80 millions.The company suffered a huge decline of -75.71% to Rs. 308.40  millions from Rs. 1269.60 millions  of corresponding previous quarter.A decline of 543.10 millions was observed in the OP in the quarter ended September 2021 from 1757.80 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 5378.80 5334.80 0.82 10563.90 9935.90 6.32 19669.80 18944.70 3.83
Other Income 105.10 44.80 134.60 162.30 102.80 57.88 243.00 160.20 51.69
PBIDT 543.10 1757.80 -69.10 1701.80 3337.00 -49.00 6161.40 5899.00 4.45
Interest 18.90 11.10 70.27 36.60 29.30 24.91 58.30 209.30 -72.15
PBDT 524.20 1746.70 -69.99 1525.90 3307.70 -53.87 6103.10 5689.70 7.27
Depreciation 108.00 96.20 12.27 211.20 189.80 11.28 389.20 357.30 8.93
PBT 416.20 1650.50 -74.78 1314.70 3117.90 -57.83 5713.90 5332.40 7.15
TAX 107.80 380.90 -71.70 336.30 572.90 -41.30 1268.30 1719.50 -26.24
Deferred Tax 3.30 -36.70 -108.99 -2.90 -219.00 -98.68 -187.20 10.50 -1882.86
PAT 308.40 1269.60 -75.71 978.40 2545.00 -61.56 4445.60 3612.90 23.05
Equity 587.10 587.10 0.00 587.10 587.10 0.00 587.10 568.90 3.20
PBIDTM(%) 10.10 32.95 -69.36 16.11 33.59 -52.03 31.32 31.14 0.60
Peers
Company Name CMP
Sun Pharma. Inds. 1864.00
Dr. Reddys Labs. 1140.80
Cipla 1380.00
Lupin 2075.00
Zydus Lifesciences 1118.00
View more..